Main description:

A unique point-of-care guide to clinical hematology-oncology
Hematology-Oncology Clinical Questions answers the questions most frequently asked by medical students or residents on rotations. The answers provided are concise, specific, evidence-based, and supported by recent references and clinical practice guidelines. Readers will find Hematology-Oncology Clinical Questions to be single-best resource for quickly translating the most current knowledge into practical, diagnostic real-time solutions.
* Coverage includes both solid tumor and hematology malignancies, cancer screening and genetic and familial cancer syndrome, supportive care and end of life, chemotherapy agents (including immunotherapy)* The content arrangement is designed to simulate the consultation process: data collection, synthesis of data, solution

Contents:

Table of Contents

1. CHEMOTHERAPY AGENTS -WILL INCLUDE A SUMMARY OF EACH TYPE BEFORE CLINICAL QUESTIONS

a. Cytotoxic

b. Targeted Agents

c. Hormonal Agents

d. Immunotherapy

2. RADIATION THERAPY

3. MOST COMMON HEME QUESTIONS

a. Anemia

b. Thrombocytopenia

c. Thrombosis

d. Transfusion reactions

4. SCREENING

a. Breast cancer

b. Cervical

c. Colon Cancer

d. Prostate

e. Lung Cancer

5. BREAST CANCER

a. Non-invasive

b. Invasive

c. Inflammatory breast cancer

d. Phyllodes

e. Paget's

6. HEAD AND NECK

7. THYROID CARCINOMAS

8. GI CANCER

a. Esophagus

b. Gastric/GEJ

c. Colon

d. Rectal

e. Anus

f. Pancreas

g. Cholangiocarcinoma

h. Hepatocellular Carcinoma

i. Neuroendocrine tumors

9. GU CANCER

a. Bladder

b. Kidney

c. Prostate

d. Testicular

10. GYNECOLOGICAL MALIGNANCIES

a. Cervical

b. Endometrial

c. Ovarian

d. Uterine

11. MELANOMAS

12. THORACIC

a. Small cell lung cancer

b. Non-small cell lung cancer

13. SARCOMAS

14. OCCULT PRIMARY

15. BASICS OF PATHOLOGY AND HEMATOLOGY

a. Bone Marrow, Flow Cytometry, Cytogenetics, Molecular testing.

b. Solid tumor pathology basics

16. BASICS OF BONE MARROW TRANSPLANTATION

a. Types (Allo, Auto)

b. Indications

17. LYMPHOMAS

a. Hodgkin's Lymphoma

i. Classical HL

ii. Nodular lymphocyte-predominant HL

b. Non-Hodgkin's Lymphoma

i. B-cell NHL

a) Diffuse large B-cell Lymphoma (DLBCL)

b) Follicular Lymphoma

c) Mantle Cell Lymphoma (MCL)

d) Small Lymphocytic Lymphoma (SLL)

e) Primary CNS Lymphoma

f) Primary Mediastinal Lymphoma (PML)

g) Burkitt Lymphoma (BL)

h) Primary Effusion Lymphoma

i) Double-hit Lymphoma

j) Primary Effusion Lymphoma (PEL)

ii. T-Cell NHL

a) Peripheral T-cell Lymphoma (PTCL)

b) Primary Cutaneous T-cell Lymphoma

c) Anaplastic Large Cell Lymphoma (ALCL)

d) Post-Transplant Lymphoproliferative

18. LEUKEMIAS

a) Acute Leukemias

i. Acute Myeloid Leukemia (AML)

ii. APL

i. Acute Lymphoblastic Leukemia (ALL)

b) Chronic Leukemias:

i. Chronic Myeloid Leukemia (CML)

ii. Chronic Lymphocytic Leukemia (CLL)

iii. Hairy Cell Leukemia

19. PLASMA CELL DISORDERS:

a. Monoclonal Gammopathy of Undetermined Significance (MGUS)

b. Multiple Myeloma (MM)

c. Lymphoplasmacyctic Lymphoma (including Waldenstrom's Macroglobulinemia)

d. Solitary Plasmacytoma

e. AL Amyloidosis

f. POEMS Syndrome

20. MYELOPROLIFERATIVE NEOPLASMS

a. Polycythemia Vera (PV)

b. Essential Thrombocythemia (ET)

c.